Myc pathways provoking cell suicide and cancer

被引:354
作者
Nilsson, JA [1 ]
Cleveland, JL [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA
基金
美国国家卫生研究院;
关键词
Myc; apoptosis; Arf; p53; Bcl-2; death receptors; cancer;
D O I
10.1038/sj.onc.1207261
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A paradox for the cancer biology field has been the revelation that oncogenes, once thought to simply provide advantages to a cancer cell, actually put it at dire risk of cell suicide. Myc is the quintessential oncogene in this respect, as in normal cells it is required for cell cycle traverse, whereas in cancers it is overexpressed and functions as the angiogenic switch. Nonetheless, Myc overexpression kills normal cells dead in their tracks. Here we review Myc-induced pathways that contribute to the apoptotic response. Molecular analysis of Myc-induced tumors has established that some of these apoptotic pathways are essential checkpoints that guard the cell from cancer, as they are selectively bypassed during tumorigenesis. The precise mechanism(s) by which Myc targets these pathways are largely unresolved, but we propose that they involve crosstalk and feedback regulatory loops between arbiters of cell death.
引用
收藏
页码:9007 / 9021
页数:15
相关论文
共 304 条
[81]   Organelle-specific initiation of cell death pathways [J].
Ferri, KF ;
Kroemer, G .
NATURE CELL BIOLOGY, 2001, 3 (11) :E255-E263
[82]   The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor [J].
Fox, CJ ;
Hammerman, PS ;
Cinalli, RM ;
Master, SR ;
Chodosh, LA ;
Thompson, CB .
GENES & DEVELOPMENT, 2003, 17 (15) :1841-1854
[83]   Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6 [J].
Freedman, DA ;
Levine, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :7288-7293
[84]   ENFORCED EXPRESSION OF THE C-MYC ONCOGENE INHIBITS CELL-DIFFERENTIATION BY PRECLUDING ENTRY INTO A DISTINCT PREDIFFERENTIATION STATE IN G0/G1 [J].
FREYTAG, SO .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (04) :1614-1624
[85]  
Fridman JS, 2003, CANCER RES, V63, P5703
[86]   The complexity of p53 modulation: emerging patterns from divergent signals [J].
Giaccia, AJ ;
Kastan, MB .
GENES & DEVELOPMENT, 1998, 12 (19) :2973-2983
[87]   The N-myc and c-mjc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2 [J].
Godfried, MB ;
Veenstra, M ;
Von Sluis, P ;
Boon, K ;
Von Asperen, R ;
Hermus, MC ;
Von Schaik, BDC ;
Voûte, TPA ;
Schwab, M ;
Versteeg, R ;
Caron, HN .
ONCOGENE, 2002, 21 (13) :2097-2101
[88]   Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1 [J].
Gostissa, M ;
Hengstermann, A ;
Fogal, V ;
Sandy, P ;
Schwarz, SE ;
Scheffner, M ;
Del Sal, G .
EMBO JOURNAL, 1999, 18 (22) :6462-6471
[89]   The Myc/Max/Mad network and the transcriptional control of cell behavior [J].
Grandori, C ;
Cowley, SM ;
James, LP ;
Eisenman, RN .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2000, 16 :653-699
[90]   Activation-induced cell death in T cells [J].
Green, DR ;
Droin, N ;
Pinkoski, M .
IMMUNOLOGICAL REVIEWS, 2003, 193 (01) :70-81